Cerenome, Inc.
CNSY· Nasdaq
CNSYCerenome, Inc.
Filed Feb 22, 2021 · 10-K · 53 days after period end · 0001564590-21-007165
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017 |
|---|---|---|---|---|
| Revenue | — | — | $1.42M | $662.00K |
| Net Income | -$3.59M | $884.00K | -$2.24M | -$4.29M |
| EPS Diluted | — | — | — |
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
| -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2020 · filed Feb 22, 2021 · 53 d after period end
